TPIDB > Principal Investigator
Principal Investigator
Linkou Chang Gung Medical Foundation
(在職)
Division of Nuclear Medicine
Division of Urology
Division of Hematology & Oncology
更新時間：2023-09-19
劉豐源Liu, Feng-Yuan
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
-
billliufy@gmail.com
Publication
3Publications
1
Liu FY, Su TP, Wang CC, Chao A, Chou HH, Chang YC, Yen TC, Lai CH*. Roles of posttherapy 18F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy. European Journal of Nuclear Medicine & Molecular Imaging 2018;45(7):1197-1204. (SCI, 7.704, 6/124)
2
Tzu-Pei Su, Gigin Lin, Yu-Ting Huang, Feng-Yuan Liu (通訊作者), Chun-Chieh Wang, Angel Chao, Hung-Hsueh Chou, Tzu-Chen Yen, Chyong-Huey Lai. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy. European Journal of Nuclear Medicine & Molecular Imaging 2018;45(5):727-34. (SCI, 7.704, 6/124)
3
Lin G, Yang LY, Lin YC, Huang YT, Liu FY, Wang CC, Lu HY, Chiang HJ, Chen YR, Wu RC, Ng KK, Yen TC, Lai CH*. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy. European Radiology 2019;29(2):556-565. (SCI, 3.640, 18/124)
